Delivery Order SPE2DB22D3009-SPE2DB25FAU16

Award Date 3/27/25
Potential Completion Date 3/28/25
Potential Value $5.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lidocaine 5% Patches. The Firm Fixed Price delivery order, valued at $2,744.04, has an ultimate completion date of May 15, 2025. The contract is not set aside and represents an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, identified as SPE2DB22D3004|SPE2DB25FPH90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is for the delivery of Lidocaine 5% Patches, a medical product used for pain management. The contract has a ceiling value of $1,164.78 and an ultimate completion date of January 31, 2025. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,959.28, is for the delivery of Lidocaine 5% Patches over the period ending January 2, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Lidocaine 5% Patches. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $3,535.20 and an ultimate completion date of May 20, 2025. The contract is not set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with ID SPE2DB20D7059|SPE2DB25FQAE8, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,583.62 firm fixed-price delivery order is for the supply of Lidocaine 5% Patches and has a completion date of February 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Lidocaine 5% Patches. The $2,469.18 firm fixed-price contract has a completion date of May 12, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
This contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lidocaine 5% Patches. The contract has a ceiling value of $9,738.57 and an ultimate completion date of May 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,264.96 firm fixed-price delivery order is for the supply of Lidocaine 5% patches, a medication used for pain management. The contract has an ultimate completion date of July 2, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Lidocaine 5% Patches to support federal healthcare programs. The $2,732.06 contract has an ultimate completion date of July 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a broad range of medical commodities to military treatment facilities...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,351.70 and is for the delivery of Lidocaine 5% Patches. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a...
  • SPE2DB22D3009
    Indefinite Delivery Contract
  • SPE2DB22D3009-SPE2DB25FAU16
    Delivery Order

This federal contract award, with ID SPE2DB22D3009|SPE2DB25FAU16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is for the delivery of Lidocaine 5% Patches with an ultimate completion date of March 28, 2025 and a ceiling value of $5,745.87.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 6/26/25, 10:21 AM